Option chain shows key data for BlackRock Health Sciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for BlackRock Health Sciences.

BlackRock Health Sciences (NYSE:BMEZ) Stock, Option Chain

BlackRock Health Sciences

BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.

BlackRock Health Sciences Term Trust Common Shares of Beneficial Interest

BlackRock Health Sciences Trust II

<p>The DOC will disburse the Awards funding to the Company based on the achievement of various milestones, with each disbursement reimbursing the Company for eligible uses of funds already incurred and paid by the Company. Disbursements are Project-specific and subject to the achievement of various capital expenditure, facility development, production qualification, the receipt of applicable permits and other governmental approvals, and various other conditions.</p>
<p><br />&nbsp;</p>


News

INFN

On January 16, 2025, Infinera Entered Into Direct Funding Agreement For Up To $93M With US Department Of Commerce  Under CHIPS Act - Filing

<p><strong>Intuitive Surgical Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported financial results for the fourth quarter after the market close on Thursday. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/01/g43176400/intuitive-announces-fourth-quarter-earnings">from the quarter.</a></p>
<p><strong>Q4 Earnings:</strong> Intuitive Surgical reported fourth-quarter revenue of $2.41 billion, beating the&nbsp;<a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus estimate</a>&nbsp;of $2.25 billion. The robotic-assisted surgery company reported fourth-quarter adjusted earnings of $2.21 per share, beating analyst estimates of $1.79 per share, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.</p>
<p>Revenue climbed 25% on a year-over-year basis. Worldwide da Vinci procedures increased approximately 18% year-over-year. The company said it&nbsp;placed 493 da Vinci surgical systems in the quarter, versus 415 in the prior year's quarter. Fourth-quarter placements included 174 da Vinci 5 systems. Intuitive Surgical's da Vinci surgical system installed base totaled 9,902 systems as of Dec. 31, up 15% year-over-year. </p>
<p>The company ended the quarter with $8.83 billion in cash, cash equivalents and investments, up $521 million during the quarter.</p>
<p><strong>Outlook:</strong> Intuitive Surgical expects full-year 2025 worldwide da Vinci procedures to increase approximately&nbsp;13%&nbsp;to&nbsp;16%. The company expects gross profit margin to be between&nbsp;67%&nbsp;and&nbsp;68%&nbsp;of net revenue in 2025.</p>
<p>Intuitive shares were down 0.1% after hours at last check, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The stock moved higher last week after the company reported preliminary results ahead of a presentation at the annual JPMorgan Healthcare Conference. The muted response on Thursday is likely due to the preliminary report. </p>
<p>&#8220;We are pleased with customer adoption of da Vinci 5, Ion, and SP during the quarter and full year. We remain focused on delivering the goals we share with our customers, centered on improving patient outcomes,&#8221; Intuitive Surgical CEO <strong>Gary Guthart</strong> said in the preliminary release.</p>
<p>Management will further discuss the quarter on a conference call with analysts and investors at 4:30 p.m. ET.</p>
<p><strong>Read Next:</strong></p>
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/previews/25/01/43174420/verizon-q4-earnings-preview-company-show-5g-growth-reverse-streak-revenue-misses"><strong>Verizon Q4 Earnings Preview: Will Company Show 5G Growth, Reverse Streak Of Revenue Misses?</strong></a></li>
</ul>
<p><em>Photo: Courtesy of Intuitive Surgical.</em></p>


Earnings

Health Care

After-Hours Center

Movers

ISRG

Intuitive Surgical Q4 Earnings: Revenue Beat, EPS Beat, Da Vinci Procedures Jump 18% And More

<p><strong>CSX</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) announced its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>CSX missed estimated earnings by 0.0%, reporting an EPS of $0.42 versus an estimate of $0.42.</p>
<p>Revenue was down $140.00 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company missed on EPS by $0.02 in the previous quarter, leading to a 7.000000000000001% drop share price change the next day.</p>
<p>Here's a look at CSX's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.48</td>
<td>0.48</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.46</td>
<td>0.49</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>3.67B</td>
<td>3.70B</td>
<td>3.66B</td>
<td>3.63B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>3.62B</td>
<td>3.70B</td>
<td>3.68B</td>
<td>3.68B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for CSX <a href="https://www.benzinga.com/quote/CSX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: CSX Q4

<p>The Q4 earnings report for <strong>Intuitive Surgical</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) was released on Thursday, January 23, 2025 at 04:04 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Intuitive Surgical beat estimated earnings by 23.0%, reporting an EPS of $2.21 versus an estimate of $1.79.</p>
<p>Revenue was up $485.70 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company beat on EPS by $0.21 in the last quarter, resulting in a 10.0% increase share price change the following day.</p>
<p>Here's a look at Intuitive Surgical's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.63</td>
<td>1.54</td>
<td>1.41</td>
<td>1.48</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.84</td>
<td>1.78</td>
<td>1.50</td>
<td>1.60</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>2.00B</td>
<td>1.97B</td>
<td>1.87B</td>
<td>1.87B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>2.04B</td>
<td>2.01B</td>
<td>1.89B</td>
<td>1.93B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Intuitive Surgical <a href="https://www.benzinga.com/quote/ISRG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into Intuitive Surgical Q4 Earnings

<p><strong>Texas Instruments</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) just disclosed its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>Texas Instruments beat estimated earnings by 8.0%, reporting an EPS of $1.3 versus an estimate of $1.2.</p>
<p>Revenue was down $70.00 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>The company beat on EPS by $0.09 in the previous quarter, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at Texas Instruments's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.38</td>
<td>1.17</td>
<td>1.07</td>
<td>1.46</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.47</td>
<td>1.22</td>
<td>1.20</td>
<td>1.49</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>4.12B</td>
<td>3.82B</td>
<td>3.61B</td>
<td>4.12B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>4.15B</td>
<td>3.82B</td>
<td>3.66B</td>
<td>4.08B</td>
</tr>
</tbody>
</table>
</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Guidance</h3>
<p>Texas Instruments management provided guidance for Q1 2025, expecting earnings between $0.94 and $1.16 per share.</p>
<p>To track all earnings releases for Texas Instruments <a href="https://www.benzinga.com/quote/TXN/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Texas Instruments Q4

<p>The earnings results for <strong>Business First Bancshares</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) for Q4 were made public on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Business First Bancshares beat estimated earnings by 35.0%, reporting an EPS of $0.66 versus an estimate of $0.49.</p>
<p>Revenue was up $17.41 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company beat on EPS by $0.11, resulting in a 4.0% increase change in the share price the following day.</p>
<p>Here's a look at Business First Bancshares's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.57</td>
<td>0.51</td>
<td>0.57</td>
<td>0.60</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.64</td>
<td>0.50</td>
<td>0.66</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>65.32M</td>
<td>62.96M</td>
<td>62.22M</td>
<td>62.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>66.90M</td>
<td>66.19M</td>
<td>60.92M</td>
<td>60.17M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Business First Bancshares <a href="https://www.benzinga.com/quote/BFST/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


BFST

Business First Bancshares: Q4 Earnings Insights

<p><strong>East West Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) just disclosed its Q4 earnings on Thursday, January 23, 2025 at 04:05 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>East West Bancorp missed estimated earnings by -2.0%, reporting an EPS of $2.08 versus an estimate of $2.12.</p>
<p>Revenue was up $12.79 million from the same period last year.</p>
<h3>Past Earnings Performance</h3>
<p>The company beat on EPS by $0.03 in the last quarter, resulting in a 6.0% increase share price change the following day.</p>
<p>Here's a look at East West Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.06</td>
<td>1.97</td>
<td>2</td>
<td>1.89</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.09</td>
<td>2.07</td>
<td>2.08</td>
<td>2.02</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>561.26M</td>
<td>554.96M</td>
<td>581.10M</td>
<td>576.55M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>572.72M</td>
<td>553.23M</td>
<td>565.14M</td>
<td>574.83M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for East West Bancorp <a href="https://www.benzinga.com/quote/EWBC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


EWBC

East West Bancorp Earnings Report: Q4 Overview

<p><strong>SouthState</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) reported its Q4 earnings results on Thursday, January 23, 2025 at 04:05 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>SouthState beat estimated earnings by 12.0%, reporting an EPS of $1.93 versus an estimate of $1.72.</p>
<p>Revenue was up $30.60 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company beat on EPS by $0.26, resulting in a 1.0% increase change in the share price the following day.</p>
<p>Here's a look at SouthState's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>1.64</td>
<td>1.54</td>
<td>1.55</td>
<td>1.54</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>1.90</td>
<td>1.79</td>
<td>1.58</td>
<td>1.67</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>429.33M</td>
<td>418.08M</td>
<td>414.33M</td>
<td>417.72M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>426.41M</td>
<td>425.48M</td>
<td>415.49M</td>
<td>419.72M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for SouthState <a href="https://www.benzinga.com/quote/SSB/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SouthState Earnings Review: Q4 Summary

<p>The Q4 earnings report for <strong>OceanFirst Financial</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) was released on Thursday, January 23, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>OceanFirst Financial beat estimated earnings by 3.0%, reporting an EPS of $0.38 versus an estimate of $0.37.</p>
<p>Revenue was down $4.50 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>Last quarter the company beat on EPS by $0.01 which was followed by a 2.0% drop in the share price the next day.</p>
<p>Here's a look at OceanFirst Financial's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.38</td>
<td>0.43</td>
<td>0.41</td>
<td>0.43</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.39</td>
<td>0.39</td>
<td>0.44</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>83.18M</td>
<td>85.46M</td>
<td>87.40M</td>
<td>90.36M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>82.22M</td>
<td>82.26M</td>
<td>86.22M</td>
<td>87.82M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for OceanFirst Financial <a href="https://www.benzinga.com/quote/OCFC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


OCFC

OceanFirst Financial: Q4 Earnings Insights

<p>NextEra Energy Partners, LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) today announced the company is changing its name to XPLR Infrastructure, LP, effective today, and will begin trading under the new ticker symbol, XIFR, on the New York Stock Exchange (NYSE) on Tuesday, Feb. 3, 2025.</p>


NextEra Energy Partners, LP To Be Renamed XPLR Infrastructure, LP, Effective Today; Will Begin Trading Under The New Ticker Symbol, "XIFR" On The NYSE On Tuesday, Feb. 3, 2025.

<p>The Q4 earnings report for <strong>Byline Bancorp</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BY#NYSE">BY</a>) was released on Thursday, January 23, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>Byline Bancorp beat estimated earnings by 13.0%, reporting an EPS of $0.69 versus an estimate of $0.61.</p>
<p>Revenue was up $3.88 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.05, leading to a 1.0% increase share price change the next day.</p>
<p>Here's a look at Byline Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.65</td>
<td>0.63</td>
<td>0.63</td>
<td>0.67</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.70</td>
<td>0.68</td>
<td>0.70</td>
<td>0.73</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>101.08M</td>
<td>99.23M</td>
<td>98.06M</td>
<td>101.40M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>101.84M</td>
<td>99.37M</td>
<td>101.01M</td>
<td>100.79M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Byline Bancorp <a href="https://www.benzinga.com/quote/BY/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: Byline Bancorp Q4

<p>The Q4 earnings report for <strong>SB Finl Gr</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) was released on Thursday, January 23, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>SB Finl Gr beat estimated earnings by 27.0%, reporting an EPS of $0.52 versus an estimate of $0.41.</p>
<p>Revenue was up $339 thousand from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company missed on EPS by $0.01 in the last quarter, resulting in a 6.0% drop share price change the following day.</p>
<p>Here's a look at SB Finl Gr's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.42</td>
<td>0.35</td>
<td>0.30</td>
<td>0.35</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.41</td>
<td>0.46</td>
<td>0.33</td>
<td>0.57</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>9.70M</td>
<td>9.40M</td>
<td>9.50M</td>
<td>9.40M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>14.31M</td>
<td>14.04M</td>
<td>13.13M</td>
<td>15.12M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for SB Finl Gr <a href="https://www.benzinga.com/quote/SBFG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


SBFG

SB Finl Gr Q4 Earnings Assessment

<p>The Q4 earnings report for <strong>First Bank</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) was released on Thursday, January 23, 2025 at 04:37 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>First Bank beat estimated earnings by 8.0%, reporting an EPS of $0.42 versus an estimate of $0.39.</p>
<p>Revenue was up $5.77 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company missed on EPS by $0.06 in the previous quarter, leading to a 5.0% drop share price change the next day.</p>
<p>Here's a look at First Bank's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.40</td>
<td>0.40</td>
<td>0.42</td>
<td>0.39</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.34</td>
<td>0.47</td>
<td>0.49</td>
<td>0.49</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>31.55M</td>
<td>30.31M</td>
<td>31.41M</td>
<td>29.58M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>32.57M</td>
<td>31.23M</td>
<td>32.28M</td>
<td>28.00M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for First Bank <a href="https://www.benzinga.com/quote/FRBA/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


FRBA

Earnings Breakdown: First Bank Q4

<p>BayCom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCML#NASDAQ">BCML</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.51 by 7.84 percent. This is unchanged from the same period last year.</p>


Earnings Beats

BCML

BayCom Q4 EPS $0.55 Beats $0.51 Estimate

<p><strong>Moderna Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) shares closed up Thursday gaining momentum following recent comments by Oracle Chairman <strong>Larry Ellison</strong> about the role of artificial intelligence in<a href="https://www.benzinga.com/general/health-care/25/01/43145442/moderna-shares-are-up-today-whats-going-on"> revolutionizing cancer treatment.</a></p>
<p><strong>What To Know: </strong>Ellison, speaking at a White House event, highlighted AI&#8217;s potential to analyze blood tests for early cancer detection, identify tumor fragments and sequence cancer genes to create personalized mRNA vaccines. He claimed AI-driven automation could enable the production of these vaccines within 48 hours, significantly expediting personalized treatment.</p>
<p>The remarks were made as part of the announcement of Stargate, a $500 billion private-sector initiative led by OpenAI, SoftBank and Oracle to develop large-scale AI infrastructure in the U.S. President <strong>Donald Trump </strong>emphasized the project&#8217;s significance in advancing AI capabilities and creating over 100,000 jobs.</p>
<p>The initiative includes the construction of 20 massive data centers, with the first already underway in Texas. These facilities will support AI applications in healthcare, including electronic health record analysis and advanced diagnostics.</p>
<p><strong>MRNA Price Action:</strong> Moderna shares closed Thursday up 10.10% at $42.39, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072924&amp;t=be2bearmibe3na1">Benzinga Pro.</a></p>
<p><figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="527" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-1024x527.png" alt="" class="wp-image-747744" style="width:544px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-1024x527.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45-768x395.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23161919/Screenshot-2025-01-23-at-16.18.45.png 1393w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure></p>
<p><strong>Read Next:</strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/specialty-etfs/25/01/43160029/tesla-nvidia-etfs-in-the-works-to-tap-rising-interest-in-same-day-stock-options">Tesla, Nvidia ETFs In The Works To Tap Rising Interest In Same-Day Stock Options</a></strong></li>
</ul>
<p><em>Photo: Shutterstock.</em></p>


Biotech

MRNA

Moderna Shares Are Up Today: What's Going On?

<p>USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) reported quarterly earnings of $0.34 per share which missed the analyst consensus estimate of $0.36 by 5.56 percent. This is a 100 percent increase over earnings of $0.17 per share from the same period last year.  The company reported quarterly sales of $22.98 million which beat the analyst consensus estimate of $22.41 million by 2.57 percent.  This is a 46.38 percent increase over sales of $15.70 million the same period last year.</p>


Earnings Misses

USCB

USCB Financial Holdings Q4 Adj $0.34 Misses $0.36 Estimate, Sales $22.98M Beat $22.41M Estimate

<p>The earnings results for <strong>CSX</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) for Q4 were made public on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>CSX missed estimated earnings by 0.0%, reporting an EPS of $0.42 versus an estimate of $0.42.</p>
<p>Revenue was down $140.00 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>Last quarter the company missed on EPS by $0.02 which was followed by a 7.000000000000001% drop in the share price the next day.</p>
<p>Here's a look at CSX's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.48</td>
<td>0.48</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.46</td>
<td>0.49</td>
<td>0.46</td>
<td>0.45</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>3.67B</td>
<td>3.70B</td>
<td>3.66B</td>
<td>3.63B</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>3.62B</td>
<td>3.70B</td>
<td>3.68B</td>
<td>3.68B</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for CSX <a href="https://www.benzinga.com/quote/CSX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CSX: Q4 Earnings Insights

<p><strong>Business First Bancshares</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) announced its Q4 earnings on Thursday, January 23, 2025 at 04:01 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>Business First Bancshares beat estimated earnings by 35.0%, reporting an EPS of $0.66 versus an estimate of $0.49.</p>
<p>Revenue was up $17.41 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.11, leading to a 4.0% increase share price change the next day.</p>
<p>Here's a look at Business First Bancshares's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.57</td>
<td>0.51</td>
<td>0.57</td>
<td>0.60</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.68</td>
<td>0.64</td>
<td>0.50</td>
<td>0.66</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>65.32M</td>
<td>62.96M</td>
<td>62.22M</td>
<td>62.47M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>66.90M</td>
<td>66.19M</td>
<td>60.92M</td>
<td>60.17M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Business First Bancshares <a href="https://www.benzinga.com/quote/BFST/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Summary: Business First Bancshares Q4

<p>The earnings results for <strong>Covenant Logistics Gr</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVLG#NYSE">CVLG</a>) for Q4 were made public on Thursday, January 23, 2025 at 04:05 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>Covenant Logistics Gr missed estimated earnings by 0.0%, reporting an EPS of $0.49 versus an estimate of $0.49.</p>
<p>Revenue was up $3.35 million from the same period last year.</p>
<h3>Earnings History Overview</h3>
<p>The company missed on EPS by $0.0 in the previous quarter, leading to a 0.0% increase share price change the next day.</p>
<p>Here's a look at Covenant Logistics Gr's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.55</td>
<td>0.49</td>
<td>0.39</td>
<td>0.52</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.55</td>
<td>0.52</td>
<td>0.42</td>
<td>0.54</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>299.81M</td>
<td>292.63M</td>
<td>273.30M</td>
<td>281.75M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>258.60M</td>
<td>287.50M</td>
<td>278.76M</td>
<td>273.99M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for Covenant Logistics Gr <a href="https://www.benzinga.com/quote/CVLG/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


CVLG

Recap: Covenant Logistics Gr Q4 Earnings

<p><strong>East West Bancorp</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) released its Q4 earnings on Thursday, January 23, 2025 at 04:05 PM.</p>
<p>Here's what's important from the earnings announcement.</p>
<h3>Earnings</h3>
<p>East West Bancorp missed estimated earnings by -2.0%, reporting an EPS of $2.08 versus an estimate of $2.12.</p>
<p>Revenue was up $12.79 million from the same period last year.</p>
<h3>Performance in Previous Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.03, leading to a 6.0% increase share price change the next day.</p>
<p>Here's a look at East West Bancorp's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>2.06</td>
<td>1.97</td>
<td>2</td>
<td>1.89</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>2.09</td>
<td>2.07</td>
<td>2.08</td>
<td>2.02</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>561.26M</td>
<td>554.96M</td>
<td>581.10M</td>
<td>576.55M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>572.72M</td>
<td>553.23M</td>
<td>565.14M</td>
<td>574.83M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for East West Bancorp <a href="https://www.benzinga.com/quote/EWBC/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: East West Bancorp Q4

Press Releases

Certain BlackRock Funds Announce Final Results of Tender Offers

Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers

Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

Certain BlackRock Closed-End Funds Announce Tender Offer in Conjunction with Results of the Quarterly Measurement Period of their Discount Management Programs

Saba Capital Reaches Agreements with Two BlackRock Closed-End Funds

BlackRock Announces Board Approval of New Tender Offers for BlackRock Innovation and Growth Term Trust (BIGZ) and BlackRock Health Sciences Term Trust (BMEZ)

Comments

BlackRock Health Sciences

BlackRock Health Sciences (BMEZ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga